Based on recent data, Nurix Therapeutics, Inc. (NRIX) shows an Average True Range (ATR) of 0.9 and an Enterprise Value of 794.96M. Its average trading volume over the past 3 months is 1.13M, indicating liquidity. These fundamental metrics provide insight into NRIX's underlying financial health and market activity.
| ATR | 0.9 |
| Enterprise Value | 794.96M |
| Avg Vol (3 Months) | 1.13M |
| Avg Vol (10 Days) | 1M |
Nurix Therapeutics, Inc. (NRIX) technical indicators as of April 20, 2026: the SMA 20 is -0.53%, SMA 50 at -9.11%, and SMA 200 at 22.88%. The RSI 14 value is 45.28, suggesting its current momentum. These technical analysis signals help assess NRIX's price trends and potential future movements.
| SMA 20 | -0.53% |
| SMA 50 | -9.11% |
| SMA 200 | 22.88% |
| RSI 14 | 45.28 |
Nurix Therapeutics, Inc. (NRIX) stock performance overview as of April 20, 2026: The 52-week high is $22.5 (currently -28.4% below), and the 52-week low is $8.19 (currently 96.94% above). Over the past year, NRIX's performance is -6.41%, compared to the S&P 500's 25.03% change.
| 52-Week High | 22.5 |
| 52-Week High Chg | -28.40% |
| 52-Week Low | 8.19 |
| 52-Week Low Chg | +96.94% |
| S&P 500 52-Week Chg | 25.03% |
According to market data, Nurix Therapeutics, Inc. (NRIX) stock's recent performance metrics show that over the last month, NRIX is 0.16%, with a Year-to-Date (YTD) performance of -3.85%. Over the past year, the stock has seen a -6.41% change. These figures summarize NRIX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 17.68 | 17.68 | 20.18 | 22.5 | 22.5 | 20.18 |
| Low | 15.78 | 14.01 | 14.01 | 9 | 8.19 | 14.01 |
| Performance | -0.76% | +0.16% | +85.37% | +62.13% | -6.41% | -3.85% |
According to current financial data, NRIX stock's P/E (TTM) ratio is -6.53, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for NRIX, including P/S (21.14), P/B (4.01), and P/FCF (-5.58), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | NRIX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -6.53 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 21.14 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 4.01 | 1.07 | 0.65 | 4.99 |
| P/FCF (TTM) | -5.58 | 98.97 | -497.8 | 34.68 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep